𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors

✍ Scribed by Angela Risso; Maria Elisabetta Cosulich; Anna Rubartelli; Maria Rosaria Mazza; Antonio Bargellesi


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
714 KB
Volume
19
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors*

MLR3 molecule is a membrane glycoprotein (mol. mass range 28-34 kDa) present on activated, but not resting human peripheral T cells, B cells and thymocytes. Its kinetics of appearance on the cell surface (3 h after the addition of the inductive signal to the cells) suggests that it is an early activation antigen. The proliferative response of cultured T and B lymphocytes and thymocytes to different activation signals is inhibited by the addition of MLR3 monoclonal antibody. Moreover the antibody in combination with non-mitogenic doses of phorbol myristate acetate leads to proliferation of thymocytes and resting B and T lymphocytes. In the latter, synthesis of interleukin 2 is also induced. Biochemical analysis of MLR3 antigen indicates that it is a phosphorylated protein with N-linked sugar moieties. Together these data suggest a role for MLR3 antigen in the signal transduction process during activation, both for mature lymphocytes and for T cell precursors.


πŸ“œ SIMILAR VOLUMES


Activated human T cells express a ligand
✍ Peter Lane; AndrΓ© Traunecker; Sabine Hubele; Seiji Inui; Antonio Lanzavecchia; D πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 614 KB

## Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes To identify the ligand for the B cell-associated antigen CD40, we constructed a chimeric immunoglobulin molecule where the extracellular porti

Anti-CD3-based bispecific antibody desig
✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 107 KB πŸ‘ 2 views

## Anti -CD3 Ψ‹ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies